分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF

Lan Wang, Wenyu Zhao, Cong Xia, Zhongzheng Li, Weiming Zhao, Kai Xu, Ningdan Wang, Hui Lian, Ivan O. Rosas, Guoying Yu

Journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF:6.21

DOI:10.3390/ijms232415705

PMID:36555349

Published:2022-12-11

research field:分子生物学细胞生物学肺医学

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by fibroblast activation, excessive deposition of extracellular matrix, and progressive scarring; the pathogenesis remains elusive. The present study explored the role of Tribbles pseudokinase 3 (TRIB3), a well-known stress and metabolic sensor, in IPF.TRIB3is down-regulated in the lungs of IPF patients in comparison to control subjects. Deficiency ofTRIB3markedly inhibited A549 epithelial cells’ proliferation and migration, significantly reducing wound healing. Conversely, overexpression ofTRIB3promoted A549 cell proliferation and transmigration while it inhibited its apoptosis. Meanwhile, overexpressedTRIB3inhibited fibroblast activation and decreased ECM synthesis and deposition in MRC5 cells.TRIB3attenuated pulmonary fibrosis by negative regulation of ATF4, whileTRIB3expression markedly inhibitedATF4promoter-driven transcription activity and down-regulatedATF4expression. A co-culture system showed thatTRIB3is important to maintain the normal epithelial–mesenchymal crosstalk and regulate fibroblast activation. Taken together, our data suggested that an axis ofTRIB3–ATF4is a key mediator in IPF which might be a potential target for fibroproliferative lung disease treatment.Keywords:idiopathic pulmonary fibrosis;TRIB3;ATF4;epithelial cell;fibroblast activation

本文使用的Yeasen产品

购物车
客服
转染试用